The Swedish drugmaker picked an AI protein-design platform over rivals to engineer its next autoimmune therapies.
Microsoft Research's Quine links biology models, lab tools and published literature into one loop that already surfaced tumor-shifting compounds.
HITS, the KAIST spinout, has raised $13.4M to put AI agents that search literature, analyze data and test hypotheses into…
The Australian biotech will use Amazon's cloud and AI tools across discovery and clinical development, from target hunting to regulatory…
A Boston company working on technology licensed from Mass General Brigham wants AI to connect evidence across entire preclinical safety…
A lab led by attention-mechanism pioneer Kyunghyun Cho has a $500M commitment to build one foundation model spanning biology, clinical…
Chinese researchers layered machine learning, docking and dynamics simulation to find HY-18,623, a compound that hits two cancer-driving kinases at…
Molecule generators built to invent medicines can also design chemical weapons, and biotech is only starting to answer for that…